01 December 2020
Coulter Partners secures Chief Executive Officer for ObsEva
Coulter Partners was delighted to partner with ObsEva SA (NASDAQ: OBSV / SIX: OBSN) to secure the appointment of Brian O’Callaghan as Chief Executive Officer and member of the company’s Executive Committee, effective 1 December 2020. He will succeed Dr Ernest Loumaye and be proposed for election on ObsEva’s Board of Directors at the next company AGM. ObsEva SA is a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health.
Please refer to ObsEva’s press release published on November 9th 2020: ObsEva appoints Brian O’Callaghan as CEO
Related
-
Placement News
Top hires for VC & PE portfolio companies Q3-2023
19 October 2023
-
Placement News
Top hires for VC & PE portfolio companies Q2-2023
17 July 2023
-
Placement News
Top hires for VC & PE portfolio companies Q4-2022
23 January 2023
-
Placement News
Top hires for VC & PE portfolio companies Q4-2020
21 January 2021